Selcan Aydin

Selcan Aydin

Auto-generated profile, based on publicly available information

Selcan Aydin

The Jackson Laboratory, 600 Main Street, Bar Harbor, Maine

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2020 in Cell Stem Cell
Verified
Journal Article
Closed access
DSDaniel A. Skelly
Daniel A. Skelly
ACAnne Czechanski
Anne Czechanski
CBCandice Byers
Candice Byers
SASelcan Aydin
Selcan Aydin
CSCatrina Spruce
Catrina Spruce
LRLaura G. Reinholdt
Laura G. Reinholdt

1 September 2020 in Cell Stem Cell
Verified
Journal Article
Open access
DODaniel Ortmann
Daniel Ortmann
SBStephanie Brown
Stephanie Brown
ACAnne Czechanski
Anne Czechanski
SASelcan Aydin
Selcan Aydin
DMDaniele Muraro
Daniele Muraro
LVLudovic Vallier
Ludovic Vallier
Variability among pluripotent stem cell (PSC) lines is a prevailing issue that hampers not only experimental reproducibility but also large-scale applications and personalized cell-based therapy. This variability could result from epigenetic and genetic factors that influence stem cell behavior. Naive culture conditions minimize epigenetic fluctuation, potentially overcoming differences in PSC line differentiation potential. Here we derived PSCs from distinct mouse strains under naive conditions and show that lines from distinct genetic backgrounds have divergent differentiation capacity, confirming a major role for genetics in PSC phenotypic variability. This is explained in part through inconsistent activity of extra-cellular signaling, including the Wnt pathway, which is modulated by specific genetic variants. Overall, this study shows that genetic background plays a dominant role in driving phenotypic variability of PSCs.

23 March 2023 in Cell Genomics
Verified
Journal Article
Open access
SASelcan Aydin
Selcan Aydin
DPDuy T. Pham
Duy T. Pham
TZTian Zhang
Tian Zhang
GKGregory R. Keele
Gregory R. Keele
DSDaniel A. Skelly
Daniel A. Skelly
SMSteven C. Munger
Steven C. Munger
Genetic background drives phenotypic variability in pluripotent stem cells (PSCs). Most studies to date have used transcript abundance as the primary molecular readout of cell state in PSCs. We performed a comprehensive proteogenomics analysis of 190 genetically diverse mouse embryonic stem cell (mESC) lines. The quantitative proteome is highly variable across lines, and we identified pluripotency-associated pathways that were differentially activated in the proteomics data that were not evident in transcriptome data from the same lines. Integration of protein abundance to transcript levels and chromatin accessibility revealed broad co-variation across molecular layers as well as shared and unique drivers of quantitative variation in pluripotency-associated pathways. Quantitative trait locus (QTL) mapping localized the drivers of these multi-omic signatures to genomic hotspots. This study reveals post-transcriptional mechanisms and genetic interactions that underlie quantitative variability in the pluripotent proteome and provides a regulatory map for mESCs that can provide a basis for future mechanistic studies.

1 November 2015 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
ARAlessandro Rienzo
Alessandro Rienzo
DPDaniel Poveda-Huertes
Daniel Poveda-Huertes
SASelcan Aydin
Selcan Aydin
NBNicolas E. Buchler
Nicolas E. Buchler
APAmparo Pascual-Ahuir
Amparo Pascual-Ahuir
MPMarkus Proft
Markus Proft
Cells respond to environmental stimuli by fine tuned regulation of gene expression. Here we investigate the dose dependent modulation of gene expression at high temporal resolution upon nutrient and stress signals in yeast. The GAL1 activity in cell populations is modulated in a well defined range of galactose concentrations, correlating with a dynamic change of histone remodeling and RNAPII association. This behavior is the result of a heterogeneous induction delay by decreasing inducer concentrations across the population. Chromatin remodeling appears to be the basis for the dynamic GAL1 expression because mutants with impaired histone dynamics show severely truncated dose response profiles. In contrast, the GRE2 promoter operates like a rapid off/on switch in response to increasing osmotic stress with almost constant expression rates and exclusively temporal regulation of histone remodeling and RNAPII occupancy. The Gal3 inducer and the Hog1 MAP kinase seem to determine the different dose response strategies at the two promoters. Accordingly, GAL1 becomes highly sensitive and dose independent if previously stimulated because of residual Gal3 levels, whereas GRE2 expression diminishes upon repeated stimulation due to acquired stress resistance. Our analysis reveals important differences in the way dynamic signals create dose sensitive gene expression outputs.

17 February 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
DSDaniel A. Skelly
Daniel A. Skelly
ACAnne Czechanski
Anne Czechanski
CBCandice Byers
Candice Byers
SASelcan Aydin
Selcan Aydin
CSCatrina Spruce
Catrina Spruce
LRLaura G. Reinholdt
Laura G. Reinholdt
Mouse embryonic stem cells (mESCs) cultured under controlled conditions occupy a stable ground state where pluripotency-associated transcriptional and epigenetic circuitry are highly active. However, mESCs from some genetic backgrounds exhibit metastability, where ground state pluripotency is lost in the absence of ERK1/2 and GSK3 inhibition. We dissected the genetic basis of metastability by profiling gene expression and chromatin accessibility in 185 genetically heterogeneous mESCs. We mapped thousands of loci affecting chromatin accessibility and/or transcript abundance, including eleven instances where distant QTL co-localized in clusters. For one cluster we identifiedLifrtranscript abundance as the causal intermediate regulating 122 distant genes enriched for roles in maintenance of pluripotency. Joint mediation analysis implicated a single enhancer variant ~10kb upstream ofLifrthat alters chromatin accessibility and precipitates a cascade of molecular events affecting maintenance of pluripotency. We validated this hypothesis using reciprocal allele swaps, revealing mechanistic details underlying variability in ground state metastability in mESCs.

5 April 2024 in Science Advances
Verified
Journal Article
Open access
DCDaniel E. Cortes
Daniel E. Cortes
MEMélanie Escudero
Mélanie Escudero
AKAustin C. Korgan
Austin C. Korgan
AMArojit Mitra
Arojit Mitra
AEAlyssa Edwards
Alyssa Edwards
MPMartin F. Pera
Martin F. Pera
The power and scope of disease modeling can be markedly enhanced through the incorporation of broad genetic diversity. The introduction of pathogenic mutations into a single inbred mouse strain sometimes fails to mimic human disease. We describe a cross-species precision disease modeling platform that exploits mouse genetic diversity to bridge cell-based modeling with whole organism analysis. We developed a universal protocol that permitted robust and reproducible neural differentiation of genetically diverse human and mouse pluripotent stem cell lines and then carried out a proof-of-concept study of the neurodevelopmental gene DYRK1A . Results in vitro reliably predicted the effects of genetic background on Dyrk1a loss-of-function phenotypes in vivo. Transcriptomic comparison of responsive and unresponsive strains identified molecular pathways conferring sensitivity or resilience to Dyrk1a1A loss and highlighted differential messenger RNA isoform usage as an important determinant of response. This cross-species strategy provides a powerful tool in the functional analysis of candidate disease variants identified through human genetic studies.